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1. Introduction 
Glucose 1,6diphosphate (Glc-1,6-P,), the coen- 
zyme of phospho~ucomut~ [l-3], was postulated 
by us to play a highly spoilt role in the regulation 
of glucose metabolism in muscle (reviewed [4]). Glc- 
1 ,6-Pz participates inthe control of key enzymes, and 
is one of the strongest activators (de-inhibitors) of 
phosphofrnctokinase [S-7], the rate-limiting enzyme 
in ~ycolys~.~-2‘Udibuty~l cyclic AMP (dbc~P~ 
increases Glc-1,6-P, levels and activates phospho- 
fructokinase in the isolated rat diaphragm, mimicking 
the action of epinephrine [8]. We have also found 
that the activity of the enzyme that degrades Glc- 
1 ,6-PZ, G&1,6-P, phosphatase, undergoes changes in 
muscle; the changes are reciprocal to the levels of Glc- 
1,6-P,, under various conditions uch as starvation, 
refeeding, and muscular dystrophy [9-l 11. Here we 
have examined whether the changes in Glc-1,6-P, 
levels induced by dbcAMP in the isolated rat dia- 
phragm, can be attributed to a change in the activity 
of Glc-I ,6-P, phosphata~. In view of the ‘Yin-Yang 
Hypothesis’ [12 ] of biological regulation through the 
opposing influences of cyclic GMP and cyclic AMP, 
we also tested the influence of fl-2’-Odibutyryl 
cyclic GMP (dbcGMP) on this enzyme’s activity and 
its effects on the Glc-1 ,6-PZ levels and the activity of 
phosphofructo~ase in the isolated rat diaphragm. 
The results how that the two cyclic nucleotides exert 
opposite ffects on these parameters. 
2. Methods 
Male Charles River albino rats (80-120 g), fed ad 
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libitum or fasted for 24 h, were anesthetized with 
sodium pentobarbital. Hemidiaphragms were prepared 
asin [ 131, and incubated for 30 min at 37’C in Krebs- 
Ringer bicarbonate buffer cont~~g glucose (1 mg/ 
ml) and gassed with 95% 02-5% COz. After incuba- 
tion, the hemidiaphragms were rapidly frozen between 
a pair of aluminium tongs precooled in liquid Nz. 
Frozen diaphragms were powdered in a ,mortar cooled 
in liquid Na, and the powder was used for extraction 
of Glc-1,6-P? and enzymes. G&~-1,6-p, was extracted 
as in [8] and measured by the fluorometric method 
[ 141. Preparation of extracts and assay of phospho- 
fructokinase were as in [ 151. One milliunit of phos- 
phofructokinase activity catalyzed the formation of 
1 nmol fru-1 ,6-Pz/min at 25°C. Glc-1,6-P, phospha- 
tase was extracted and assayed as in [9]. One bust 
of Glc-1,6-P* phosphatase activity catalyzed the 
degradation of 1 nmol Glc-1,6-P,/15 min at 37°C. 
Protein was estimated by the method in [16]. 
3. Results 
Table 1 reveals that the addition of dbcAMP to the 
incubation medium of hemidiaphragms from 24 h 
fasted rats caused asignificant reduction in the activity 
of Glc-1,6-Pa phosphata~. This offers an explanation 
for the rise in Glc-1,6-P, levels induced by dbcAMP 
under identical conditions [8]. The effect of dbcAMP 
was dosedependent and was most pronounced in 
hemidiaphragms from starved rats in which the activ- 
ity of Glc-1,6-P, phosphatase is markedly elevated. 
(We had found that fasting had a similar effect on this 
enzyme’s activity in mouse leg muscle [ 111.) On the 
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Table 1 
The influence of dibutyryl cyclic AMP and dibutyryl cyclic GMP on the activity 
of Glc-1,6-P, phosphatase in the isolated rat diaphragm 
Addition to Glc-1,6-P, phosphatase activity 
incubation medium (milliunits/mg protein) 
Effect p value 
(%) 
A. 
None 
dbcAMP (2 mM) 
B. 
None 
dbcGMP 
0.95 f 0.09 (7) 
0.56 ? 0.08 (7) -40 <0.0005 
0.45 r 0.04 (6) 
0.77 + 0.04 (6) +81 <0.00005 
Paired hemidiaphragms from 24-h fasted rats (A) or from fed rats (B) were incu- 
bated for 30 min in the absence and presence of the specific cyclic nucleotide. 
Glc-1,6-P, phosphatase was prepared and assayed as in section 2. Values are 
means + SEM, with no. expt. in parentheses 
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other hand, dbcGMP induced an effect opposite to 
that of dbcAMP when added to an incubation medi- 
um of hemidiaphragms from fed rats (table 1, exp. B); 
it caused an almost 2-fold increase in Glc-1 ,6-PZ phos- 
phatase activity. Fed rats were used, as the dbcGMP 
could not activate more the already activated enzyme 
in the fasted rats. As can be seen in table 2, in correla- 
tion to the activation of Glc-1 ,6-PZ phosphatase by
dbcGMP, the Glc-1 ,6-PZ levels decreased under incu- 
bation with dbcGMP. Phosphofructokinase was 
strongly inhibited under these conditions. This inhibi- 
tion is probably a result of both the increase in its 
direct allosteric inhibitor, cyclic GMP [7], and 
decrease in its potent de-inhibitor, Glc-1 ,6-PZ. As 
seen in table 3, Glc-1 ,6-PZ had a very strong de-inhib- 
itory effect on the inhibited phosphofructokinase in 
the diaphragms incubated with dbcGMP. Cyclic AMP 
also activated the enzyme (though concentrations 
-5times higher were needed). Both activators acted 
in a concentration-dependent manner. An interesting 
finding is that when Glc-1,6-P* (2.5 PM, which 
caused a48% increase) and cyclic AMP (20 PM, which 
caused a41% increase) were added to the reaction 
mixture together, they activated the enzyme syn- 
ergistically (196% increase). 
4. Discussion 
The ‘Yin-Yang Hypothesis’ [121 suggests hat 
cyclic AMP and cyclic GMP, through their opposing 
influences, may constitute a mechanism for cellular 
regulation in many systems. These results add support 
to this hypothesis. While dbcAMP inhibits the activity 
Table 2 
The effect of dibutyryl cyclic GMP on glucose 1,6diphosphate levels and 
phosphofructokinase activity in the isolated rat diaphragm 
Glc-1,6-P, 
(Nmol/kg wet wt) 
Phosphofructokinase activity 
(milliunits/mg protein) 
Control 
dbcGMP 
% effect 
p value 
5.54 f 0.27 (11) 11.5 * 0.6 (8) 
3.67 * 0.25 (11) 5.4 f 0.3 (8) 
-33 -54 
<0.0005 <0.00005 
Paired hemidiaphragms from fed rats were incubated for 30 min in the absence 
and presence of 10 PM dibutyryl cyclic GMP (dbcGMP). Glc-1,6-P, and phos- 
phofructokinase were extracted and assayed as in section 2. ATP in the assay 
mixture for phosphofructokinase was 0.05 mM. Values are means + SEM, with 
no. expt. in parentheses 
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Table 3 
The activatory effect of glucose 1,6diphosphate and cyclic AMP on phosphofructokinase 
from diaphragms incubated with dibutyryl cyclic GMP 
Additions to Additions to Phosphofructokinase activity Effect 
incubation medium assay mixture (milliunits/mg protein) (%) 
None 
dbcGMP 
dbcGMP 
dbcGMP 
dbcGMP 
dbcGMP 
dbcGMP 
dbcGMP 
dbcGMP 
dbcGMP 
dbcGMP 
None 
None 
Glc-1,6-P, (20 PM) 
Glc-1,6-P, (10 PM) 
Glc-1,6-P, (5 PM) 
Glc-1,6-P, (2.5 MM) 
Cyclic AMP (100 PM) 
Cyclic AMP (50 FM) 
Cyclic AMP (20 PM) 
Cyclic AMP (10 NM 
Glc-1,6-P, (2.5 PM) + 
Cyclic AMP (20 PM) 
6.96 f 0.05 
2.85 ?: 0.03 
7.99 f 0.19 
6.21 r 0.08 
4.92 f 0.15 
4.25 f 0.03 
9.95 * 0.29 
6.90 + 0.09 
4.08 f 0.17 
3.77 + 0.06 
8.58 f 0.70 
-59 
+i79a 
+117 
+71 
+48 
+243 
+138 
+41 
+30 
+196 
a % activation by Glc-1,6-P, and/or cyclic AMP was calculated, in all the instances below, 
relative to phosphofructokinase activity in the dbcGMP-treated iaphragms (2.85 t 0.03 
milliunits/mg protein) 
Hemidiaphragms from fed rats were incubated for 30 min with 10 PM dibutyryl cyclic GMP 
(dbcGMP). Phosphofructokinase was prepared and assayed as in section 2, using 0.15 mM 
ATP in the assay mixture. Variable Glc-1,6-P, and cyclic AMP concentrations were added 
to the assay mixture. Values are means ?r SEM for 6 expt. For all expt. p < 0.0001 
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of Glc-1,6-P* phosphatase, dbcGMP activates it. The 
opposite influences on the Glc-1,6-P, phosphatase 
lead to inverse changes in the Glc-1 ,6-P2 levels in the 
diaphragm; dbcGMP brings about a decrease in Glc- 
1 ,6-PZ levels, while dbcAMP has been shown [8 J to 
cause a rise in Glc-1,6-P,. Phosphofructokinase, the 
key enzyme of glycolysis, changes in full agreement 
to the levels of the cyclic nucleotides and the level 
of its potent activator Glc-1,6-P?. On incubation with 
dbcGMP, the phosphofructokinase i  inhibited, prob- 
ably as a result of a combined action of the rise in 
concentration of its direct allosteric inhibitor, cyclic 
GMP, and the fall in levels of its activator (de-inhib- 
itor), Glc-1,6-P*. Adding very small concentrations of
Glc-1,6-P, can overcome the inhibition of the enzyme 
(table 3). 
We had reported that in muscular dystrophy the 
levels of Glc-1,6-P* in muscle are markedly reduced 
[17,18], while the cyclic GMPlevels rise [17]. Con- 
comitant o these changes, phosphofructokinase 
activity and glycolysis in the dystrophic muscle are 
severely depressed [ 171. In light of these results, it is 
possible that the rise in cyclic GMP in the dystrophic 
muscle leads to the decrease in the Glc-1,6-P, levels, 
through its activatory effect on the Glc-1 ,6-PZ phos- 
phatase. The activity of Glc-1 ,6-PZ phosphatase is 
markedly increased in the dystrophic muscle [9,11]. 
The strong deinhibitory effect of Glc-1,6-P, and 
cyclic @P, which act synergistically on phospho- 
fructokinase activity in muscle incubated with 
dbcGMP (table 3), leads us to believe that an increase 
in Glc-1 ,6-P2 and cyclic AMP levels will overcome the 
inhibition of phosphofructokinase by cyclic GMP. We 
are doing experiments in this direction on dystrophic 
muscle. 
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